DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Glioma Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.
US Glioma Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Glioma pipeline products, Glioma epidemiology, Glioma market valuations and forecast, Glioma products sales and competitive landscape in the US.
The research is classified into nine sections - Glioma overview including etiology, pathophysiology, and diagnosis, Glioma treatment options, Glioma pipeline products, Glioma market analysis comprising of Glioma epidemiology, key products marketed for Glioma, market valuations and forecast, products sales and market shares.
Research Scope:
- Glioma Pipeline: Find out the products in clinical trials for the treatment of Glioma by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Glioma Epidemiology: Find out the number of patients diagnosed (prevalence) with Glioma in the US
- Glioma Products: Identify key products marketed and prescribed for Glioma in the US, including trade name, molecule name, and company
- Glioma Product Sales: Find out the sales revenues of Glioma products, both branded and generics, in the US
- Glioma Market Valuations: Find out the market size for Glioma products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
- Glioma Products Market Share: Find out the market shares for key Glioma products in the US
Key Topics Covered:
- Disease Overview
- Glioma Treatments
- Glioma Pipeline
- US Glioma Epidemiology
- Marketed Drugs for Glioma in US
- US Glioma Market Size
- US Glioma Products Sales
- US Glioma Market Competitive Landscape
- US Glioma Market Forecast
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/7hv2fg/us_glioma_market
